Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents

E Feigerlova, S Pruhova, L Dittertova, J Lebl, D Pinterova, K Kolostova, M Cerna, O Pedersen, T Hansen

. 2006 ; 165 (7) : 446-452.

Language English Country Germany

Document type Research Support, Non-U.S. Gov't

Grant support
NB7420 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK SpringerLink Journals from 1997-01-01 to 2009-04-30
ProQuest Central from 1996-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 1997-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 1996-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1996-01-01 to 1 year ago
Family Health Database (ProQuest) from 1996-01-01 to 1 year ago
Public Health Database (ProQuest) from 1996-01-01 to 1 year ago

INTRODUCTION: Randomly estimated fasting hyperglycaemia in an asymptomatic individual may represent the first sign of pancreatic beta-cell dysfunction. OBJECTIVE: We aimed at specifying the genetic aetiology of asymptomatic hyperglycaemia in a cohort of children and adolescents. SUBJECTS AND METHODS: We analysed the aetiological diagnosis in 82 non-obese paediatric subjects (38 males) aged 0.2-18.5 years (median: 13.1) who were referred for elucidation of a randomly found blood glucose level above 5.5 mmol/l. In addition to fasting glycaemia and circulating levels of insulin and C-peptide, the subjects were tested by an oral glucose tolerance test and an intravenous glucose tolerance test and screened for mutations in the genes encoding glucokinase (GCK), HNF-1alpha (TCF1), Kir6.2 (KCNJ11) (if aged <2 years) and HNF-4alpha (HNF4A) (those with a positive family history of diabetes). RESULTS AND DISCUSSION: We identified 35 carriers of GCK mutations causing MODY2, two carriers of TCF1 mutations causing MODY3, one carrier of a HNF4A mutation causing MODY1 and one carrier of a KCNJ11 mutation causing permanent neonatal diabetes mellitus. Of the remaining patients, 11 progressed to type 1 diabetes mellitus (T1DM) and 9 had impaired glucose tolerance or diabetes mellitus of unknown origin. In 23 subjects, an impairment of blood glucose levels was not confirmed. We conclude that 39 of 82 paediatric patients (48%) with randomly found fasting hyperglycaemia suffered from single gene defect conditions, MODY2 being the most prevalent. An additional 11 patients (13%) progressed to overt T1DM. The aetiological diagnosis in asymptomatic hyperglycaemic children and adolescents is a clue to introducing an early and effective therapy or, in MODY2, to preventing any future extensive re-investigations.

References provided by Crossref.org

Obsahuje tabulky

000      
00000naa a2200000 a 4500
001      
bmc13010390
003      
CZ-PrNML
005      
20130402122705.0
007      
ta
008      
130319s2006 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00431-006-0106-3 $2 doi
035    __
$a (PubMed)16602010
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Feigerlová, Eva. $7 _BN001983 $u Department of Paediatrics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents / $c E Feigerlova, S Pruhova, L Dittertova, J Lebl, D Pinterova, K Kolostova, M Cerna, O Pedersen, T Hansen
500    __
$a Obsahuje tabulky
520    9_
$a INTRODUCTION: Randomly estimated fasting hyperglycaemia in an asymptomatic individual may represent the first sign of pancreatic beta-cell dysfunction. OBJECTIVE: We aimed at specifying the genetic aetiology of asymptomatic hyperglycaemia in a cohort of children and adolescents. SUBJECTS AND METHODS: We analysed the aetiological diagnosis in 82 non-obese paediatric subjects (38 males) aged 0.2-18.5 years (median: 13.1) who were referred for elucidation of a randomly found blood glucose level above 5.5 mmol/l. In addition to fasting glycaemia and circulating levels of insulin and C-peptide, the subjects were tested by an oral glucose tolerance test and an intravenous glucose tolerance test and screened for mutations in the genes encoding glucokinase (GCK), HNF-1alpha (TCF1), Kir6.2 (KCNJ11) (if aged <2 years) and HNF-4alpha (HNF4A) (those with a positive family history of diabetes). RESULTS AND DISCUSSION: We identified 35 carriers of GCK mutations causing MODY2, two carriers of TCF1 mutations causing MODY3, one carrier of a HNF4A mutation causing MODY1 and one carrier of a KCNJ11 mutation causing permanent neonatal diabetes mellitus. Of the remaining patients, 11 progressed to type 1 diabetes mellitus (T1DM) and 9 had impaired glucose tolerance or diabetes mellitus of unknown origin. In 23 subjects, an impairment of blood glucose levels was not confirmed. We conclude that 39 of 82 paediatric patients (48%) with randomly found fasting hyperglycaemia suffered from single gene defect conditions, MODY2 being the most prevalent. An additional 11 patients (13%) progressed to overt T1DM. The aetiological diagnosis in asymptomatic hyperglycaemic children and adolescents is a clue to introducing an early and effective therapy or, in MODY2, to preventing any future extensive re-investigations.
590    __
$a bohemika - dle Pubmed
650    02
$a mladiství $7 D000293
650    02
$a analýza rozptylu $7 D000704
650    02
$a přenašečství $7 D002353
650    02
$a dítě $7 D002648
650    02
$a předškolní dítě $7 D002675
650    02
$a diabetes mellitus 1. typu $x epidemiologie $x genetika $7 D003922
650    02
$a ženské pohlaví $7 D005260
650    02
$a genetické testování $7 D005820
650    02
$a glukózový toleranční test $7 D005951
650    02
$a lidé $7 D006801
650    02
$a hyperglykemie $x epidemiologie $x genetika $7 D006943
650    02
$a kojenec $7 D007223
650    02
$a mužské pohlaví $7 D008297
650    02
$a mutace $7 D009154
650    02
$a prospektivní studie $7 D011446
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Průhová, Štěpánka, $d 1974- $7 mzk2004252387 $u Department of Paediatrics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Dittertová, Lucie $7 xx0066073 $u Department of Paediatrics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Lebl, Jan, $d 1955- $7 jn19990010093 $u Department of Paediatrics, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Pintérová, Daniela $7 xx0102048 $u Department of Cellular and Molecular Biology, 3rd Faculty of Medicine, Charles University Prague, Czech Republic
700    1_
$a Kološtová, Katarína. $7 xx0207726 $u Department of Cellular and Molecular Biology, 3rd Faculty of Medicine, Charles University Prague, Czech Republic
700    1_
$a Černá, Milena, $d 1943- $7 nlk19990074185 $u Department of Cellular and Molecular Biology, 3rd Faculty of Medicine, Charles University Prague, Czech Republic
700    1_
$a Pedersen, O. $u Steno Diabetes Centre and Hagedom Research Institute, Gentofte, Denmark
700    1_
$a Hansen, T. $u Steno Diabetes Centre and Hagedom Research Institute, Gentofte, Denmark
773    0_
$t European Journal of Pediatrics $x 0340-6199 $g Roč. 165, č. 7 (2006), s. 446-452 $p Eur J Pediatr $w MED00009638
910    __
$a ABA008 $b A 703 $y 3 $z 0
990    __
$a 20130319133659 $b ABA008
991    __
$a 20130402122930 $b ABA008
999    __
$a ok $b bmc $g 973309 $s 808655
BAS    __
$a 3
BMC    __
$x MED00009638 $i 0340-6199 $a 2006 $b 165 $c 7 $d 446-452 $m European journal of pediatrics $n Eur J Pediatr
GRA    __
$a NB7420 $p MZ0
LZP    __
$a 2013-03/gvbo

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...